Metabolic syndrome: contributing factors and treatment strategies.
Metabolic syndrome is associated with increased risk for cardiovascular and cerebrovascular disease. The World Health Organization and National Cholesterol Education Program Adult Treatment Panel III have identified physiologic abnormalities associated with metabolic syndrome, including impaired glucose metabolism, high blood pressure, elevated cholesterol levels, and abdominal obesity. It is estimated that 47 million Americans have metabolic syndrome. A variety of therapies may help reduce the incidence and risk, including diet, weight loss, physical exercise, glycemic control, and pharmacological treatments. Nursing care is focused on developing an individualized plan of care that includes family members and providing education, psychosocial support, close monitoring, and continued follow-up to ensure adherence and success in achieving patient outcomes.
Fowler
Susan B
SB
University of Medicine and Dentistry of New Jersey School of Nursing, The University Hospital, Newark, NJ, USA. njfowlers761@msn.com
Moussouttas
Michael
M
Mancini
Barbara
B
D000959:Antihypertensive Agents / Q000627:therapeutic use; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000209:etiology; D018752:Diet, Fat-Restricted; D016903:Drug Monitoring / Q000451:nursing; D015444:Exercise; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008019:Life Style; D024821:Metabolic Syndrome / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D024802:Nurse's Role; D010353:Patient Education as Topic; D015995:Prevalence; D012017:Referral and Consultation; D012307:Risk Factors; D020521:Stroke / Q000209:etiology
D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents